How is Mutation Burden Related to Other Biomarkers?
Mutation burden is often used in conjunction with other biomarkers to provide a more comprehensive understanding of a patient's cancer. For example, PD-L1 expression is another important biomarker for immunotherapy response. Combining TMB with PD-L1 levels can give a clearer picture of the likelihood of a successful response to treatment.
